Steward Partners Investment Advisory, LLC Cyma Bay Therapeutics, Inc. Transaction History

Steward Partners Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$12.63 - $24.47 $28,417 - $55,057	2,250 Added 14.66%	17,600 $415,000
Q3 2023 Nov 13, 2023	BUY	$10.86 - $17.62 $166,701 - $270,467	15,350 New	15,350 $228,000
Q3 2021 Nov 12, 2021	BUY	$3.47 - $4.42 $1,731 - $2,205	499 Added 49900.0%	500 $2,000
Q2 2021 Aug 13, 2021	BUY	$3.94 - $4.92 $3 - $4	1 New	1 $0
Q4 2018 Jan 15, 2019	SELL	$6.54 - $11.74 $1,635 - $2,935	-250 Closed	0 $0
Q2 2018 Jul 20, 2018	BUY	$10.66 - $14.38 $2,665 - $3,595	250 New	250 $3,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.